GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $209,000 | -99.1% | 5,121 | -99.0% | 0.00% | -100.0% |
| Q4 2020 | $22,724,000 | -25.0% | 524,675 | -4.5% | 0.04% | -36.5% |
| Q3 2020 | $30,301,000 | -11.4% | 549,528 | +1.4% | 0.06% | -21.2% |
| Q2 2020 | $34,197,000 | +34.7% | 541,686 | +9.0% | 0.08% | +2.6% |
| Q1 2020 | $25,383,000 | -34.9% | 496,837 | +1.4% | 0.08% | -21.2% |
| Q4 2019 | $38,965,000 | +76.3% | 490,192 | +7.6% | 0.10% | +59.7% |
| Q3 2019 | $22,105,000 | +6.0% | 455,582 | +14.9% | 0.06% | +3.3% |
| Q2 2019 | $20,863,000 | -0.2% | 396,629 | +0.4% | 0.06% | +1.7% |
| Q1 2019 | $20,906,000 | +54.9% | 394,985 | +20.2% | 0.06% | +31.1% |
| Q4 2018 | $13,493,000 | +89.2% | 328,740 | +75.2% | 0.04% | +125.0% |
| Q3 2018 | $7,133,000 | – | 187,664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |